Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
1.520
+0.050 (3.40%)
At close: Jun 6, 2025, 4:00 PM
1.480
-0.040 (-2.63%)
After-hours: Jun 6, 2025, 7:40 PM EDT
Zentalis Pharmaceuticals Revenue
Zentalis Pharmaceuticals had revenue of $26.87M in the twelve months ending March 31, 2025, down -33.76% year-over-year. In the year 2024, Zentalis Pharmaceuticals had annual revenue of $67.43M.
Revenue (ttm)
$26.87M
Revenue Growth
-33.76%
P/S Ratio
4.03
Revenue / Employee
$161,837
Employees
166
Market Cap
109.37M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
ZNTL News
- 4 days ago - Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 23 days ago - Zentalis Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Progress - GlobeNewsWire
- 5 weeks ago - Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 weeks ago - Zentalis Pharmaceuticals Announces First Patient Dosed in DENALI Part 2 Clinical Trial of Azenosertib in Patients with Cyclin E1+ PROC - GlobeNewsWire
- 6 weeks ago - Zentalis Pharmaceuticals Announces Poster Presentation at 2025 ASCO Annual Meeting - GlobeNewsWire
- 2 months ago - Zentalis Pharmaceuticals Reports Full Year 2024 Financial Results and Operational Updates - GlobeNewsWire
- 2 months ago - Zentalis Pharmaceuticals to Present Multiple Posters at the American Association for Cancer Research (AACR) Annual Meeting 2025 - GlobeNewsWire
- 2 months ago - Zentalis Pharmaceuticals Presents Updated Clinical Data at the Society of Gynecologic Oncology 2025 Annual Meeting on Women's Cancer - GlobeNewsWire